BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 22814322)

  • 1. Myxoinflammatory fibroblastic sarcoma of the face.
    Gómez Martín C; Ortega MI; Aramburu JA; Fernández-Cañamaque JL
    Am J Dermatopathol; 2012 Aug; 34(6):663-5. PubMed ID: 22814322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myxoinflammatory fibroblastic sarcoma of the neck.
    McFarlane R; Meyers AD; Golitz L
    J Cutan Pathol; 2005 May; 32(5):375-8. PubMed ID: 15811125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myxoinflammatory fibroblastic sarcoma in an unreported area (groin).
    Bar-Meir E; Fridman E; Zilinsky I; Orenstein A; Winkler E
    J Cutan Pathol; 2007 Mar; 34(3):276-80. PubMed ID: 17302613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myxoinflammatory Fibroblastic Sarcoma.
    Wu H; Laskin WB
    Surg Pathol Clin; 2024 Mar; 17(1):83-96. PubMed ID: 38278610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myxoinflammatory fibroblastic sarcoma of the scalp: aggressive behavior at a rare, nonextremity site.
    Vroobel K; Miah A; Fisher C; Thway K
    Int J Surg Pathol; 2015 Jun; 23(4):292-7. PubMed ID: 25673633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unexpected Clinical Outcome for Myxoinflammatory Fibroblastic Sarcoma, When Should They Be Considered High Grade?
    Sparkman BK; Nguyen TVV; Smith SC; Bear HD
    J Investig Med High Impact Case Rep; 2023; 11():23247096231205344. PubMed ID: 37840277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGFBR3 and MGEA5 rearrangements are much more common in "hybrid" hemosiderotic fibrolipomatous tumor-myxoinflammatory fibroblastic sarcomas than in classical myxoinflammatory fibroblastic sarcomas: a morphological and fluorescence in situ hybridization study.
    Zreik RT; Carter JM; Sukov WR; Ahrens WA; Fritchie KJ; Montgomery EA; Weiss SW; Folpe AL
    Hum Pathol; 2016 Jul; 53():14-24. PubMed ID: 26980036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myxoinflammatory fibroblastic sarcoma: report of a case and review of the literature.
    Alaggio R; Coffin CM; Dall'igna P; Bisogno G; Olivotto A; Di Venosa B; Fassina A
    Pediatr Dev Pathol; 2012; 15(3):254-8. PubMed ID: 22372507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acral myxoinflammatory fibroblastic sarcoma: cytopathologic findings on fine-needle aspiration.
    Toll AD; Wakely PE; Ali SZ
    Acta Cytol; 2013; 57(2):134-8. PubMed ID: 23406831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acral myxoinflammatory fibroblastic sarcomas: MRI findings in four cases.
    Narváez JA; Martinez S; Dodd LG; Brigman BE
    AJR Am J Roentgenol; 2007 May; 188(5):1302-5. PubMed ID: 17449774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acral myxoinflammatory fibroblastic sarcoma: case series and immunohistochemical analysis.
    Kovarik CL; Barrett T; Auerbach A; Cassarino DS
    J Cutan Pathol; 2008 Feb; 35(2):192-6. PubMed ID: 18190444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acral myxoinflammatory fibroblastic sarcoma: a report of five cases and review of the literature.
    Sakaki M; Hirokawa M; Wakatsuki S; Sano T; Endo K; Fujii Y; Ikeda T; Kawaguchi S; Hirose T; Hasegawa T
    Virchows Arch; 2003 Jan; 442(1):25-30. PubMed ID: 12536311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myxoinflammatory fibroblastic sarcoma--report of a rare case at an unusual site with review of the literature.
    Premalata CS; Rama Rao C; Padma M; Vijaykumar M
    Int J Dermatol; 2008 Jan; 47(1):68-71. PubMed ID: 18173608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myxoinflammatory fibroblastic sarcoma of the nose: First reported case at an unusual location (nasal dorsum), with a review of the literature.
    Numminen J; Bizaki A; Kujansivu J; Huovinen S; Rautiainen M
    Ear Nose Throat J; 2016 Mar; 95(3):E32-5. PubMed ID: 26991227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The first case of myxoinflammatory fibroblastic sarcoma affecting the maxillary bone.
    Boran Ç; Kilitci A; Ahsen H; Yılmaz F
    Int J Health Sci (Qassim); 2022; 16(2):37-39. PubMed ID: 35300266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytopathology of myxoinflammatory fibroblastic sarcoma: a series of eight cases and review of the literature.
    Wangsiricharoen S; Ali SZ; Wakely PE
    J Am Soc Cytopathol; 2021; 10(3):310-320. PubMed ID: 33431307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case reports: acral myxoinflammatory fibroblastic sarcoma: a report of five cases and literature review.
    Lang JE; Dodd L; Martinez S; Brigman BE
    Clin Orthop Relat Res; 2006 Apr; 445():254-60. PubMed ID: 16446594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myxoinflammatory fibroblastic sarcoma showing t(2;6)(q31;p21.3) as a sole cytogenetic abnormality.
    Ida CM; Rolig KA; Hulshizer RL; Van Dyke DL; Randolph JL; Jenkins RB; Nascimento AG; Oliveira AM
    Cancer Genet Cytogenet; 2007 Sep; 177(2):139-42. PubMed ID: 17854670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acral myxoinflammatory fibroblastic sarcoma: a low-grade tumor of the hands and feet.
    Meis-Kindblom JM; Kindblom LG
    Am J Surg Pathol; 1998 Aug; 22(8):911-24. PubMed ID: 9706971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myxoinflammatory fibroblastic sarcoma: a clinicopathologic analysis of 104 cases, with emphasis on predictors of outcome.
    Laskin WB; Fetsch JF; Miettinen M
    Am J Surg Pathol; 2014 Jan; 38(1):1-12. PubMed ID: 24121178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.